Blue Water Vaccines Reports Third Quarter 2022 Financial Results and Recent Business Highlights; Announces 5 Million Share Repurchase Program
On August 11, 2022, BWV closed a private placement with aggregate net cash proceeds of approximately $8.7 million.
- On August 11, 2022, BWV closed a private placement with aggregate net cash proceeds of approximately $8.7 million.
- On November 8, 2022, the Company announced the appointment of Vuk Jeremi to its Board on November 4, 2022.
- On November 9, 2022, the Board approved a share repurchase program to allow for the Company to repurchase up to 5 million shares, with discretion to management to make purchases subject to market conditions.
- Cash Position: Cash was $29.1 million as of September 30, 2022, as compared to $1.9 million as of December 31, 2021.